Koyfin Home > Directory > Health Care > Antares Pharma > Price / Earnings (ntm)

Antares Pharma Price / Earnings (ntm) Chart (ATRS)

Antares Pharma annual/quarterly Price / Earnings (ntm) from 2010 to 2012. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Antares Pharma Price / Earnings (ntm) for the quarter ending September 09, 2012 was 109.00 a -35.17% decrease of -38.33 year over year
  • Antares Pharma Annual Price / Earnings (ntm) for 2011 was 26.47 a 12.40% increase of 3.28 from 2010
  • Antares Pharma Annual Price / Earnings (ntm) for 2010 was 23.19
Other Valuation Metrics:
  • Antares Pharma Market Cap for the quarter ending March 03, 2018 was $345m a -45.56% decrease of -157m year over year
  • Antares Pharma Price / Book for the quarter ending March 03, 2018 was 10.27 a -17.66% decrease of -1.81 year over year
  • Antares Pharma Enterprise Value for the quarter ending March 03, 2018 was $338m a -41.44% decrease of -140m year over year
View Chart On Koyfin

Quarterly ATRS Price / Earnings (ntm) Data

09/2012109.00
12/201126.47
09/201143.53
06/2011147.33
12/201023.19
09/2010109.02
06/201088.00

Annual ATRS Price / Earnings (ntm) Data

201126.47
201023.19